Therese Törngren

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma

Martin Lauss, Marco Donia, Katja Harbst et al. · Nature Communications · 2017 · 497 citations · Full text

Life Sciences, Immunology, Oncology +17

Molecular stratification of metastatic melanoma using gene expression profiling : Prediction of survival outcome and benefit from molecular targeted therapy

Helena Cirenajwis, Henrik Ekedahl, Martin Lauss et al. · Oncotarget · 2015 · 192 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +17

Large scale multifactorial likelihood quantitative analysis of <i>BRCA1</i> and <i>BRCA2</i> variants: An ENIGMA resource to support clinical variant classification

Michael T. Parsons, Emma Tudini, Hongyan Li et al. · Human Mutation · 2019 · 152 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic

Christof Winter, Martin Nilsson, Eric Olsson et al. · Annals of Oncology · 2016 · 150 citations · Full text

Medicine, Genetics, Oncology +16

<i><scp>NF</scp>1</i>‐mutated melanoma tumors harbor distinct clinical and biological characteristics

Helena Cirenajwis, Martin Lauss, Henrik Ekedahl et al. · Molecular Oncology · 2017 · 134 citations · Full text

Medicine, Genetics, Oncology +17